Ping An Biomedical Co., Ltd.
PASW
Analytical Summary
Ping An Biomedical Co., Ltd. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.
Bullish Indicators
- No bullish signals detected.
Bearish Risks
- Operating Margin (%)Operating Margin (%) is in the bottom quartile
- Profit Margin (%)Profit Margin (%) is in the bottom quartile
- Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile
Health Breakdown
Statement lens
Choose the reporting cadence, isolate a period range, or search directly for a metric.
| Metric | FY 2025 Sep 30, 2025 20-F ↗ | FY 2024 Sep 30, 2024 20-F ↗ | FY 2023 Sep 30, 2023 20-F ↗ |
|---|---|---|---|
| Operating Margin (%) (%) |
-43.1%
Weak
Weak
Operating income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-459%)
|
— | — |
| Effective Tax Rate (%) (%) |
-12.6%
Excellent
Excellent
Actual taxes paid relative to pre-tax income
Optimal:
15-25%
|
— | — |
| Profit Margin (%) (%) |
-37.6%
Weak
Weak
Net income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-570%)
|
— | — |
| FCF Margin (%) (%) |
-18.8%
Weak
Weak
Free cash flow as a percentage of revenue
Optimal:
> 10%
|
— | — |
| FCF / Net Income (x) |
0.50x
Weak
Weak
Free cash flow relative to reported net income
Optimal:
> 1x
|
— | — |
| Metric | FY 2025 Sep 30, 2025 20-F ↗ | FY 2024 Sep 30, 2024 20-F ↗ | FY 2023 Sep 30, 2023 20-F ↗ |
|---|---|---|---|
| Return on Invested Capital (%) |
-36.6%
Weak
Weak
Return earned on debt + equity capital invested
Optimal:
> 10%
|
— | — |
| Return on Capital (%) (%) |
-21.5%
Weak
Weak
Operating profit relative to total assets
Optimal:
> 10%
|
— | — |
| Return on Common Equity (%) (%) |
-28.4%
Weak
Weak
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-242%)
|
— | — |
| Metric | FY 2025 Sep 30, 2025 20-F ↗ | FY 2024 Sep 30, 2024 20-F ↗ | FY 2023 Sep 30, 2023 20-F ↗ |
|---|---|---|---|
| Debt to Equity (x) |
0.22x
Excellent
Excellent
Total debt relative to shareholder equity
Optimal:
< 0.6x
vs Sector:
Below avg (-72%)
|
— | — |
| Interest Coverage (x) |
-47.29x
Weak
Weak
Operating income divided by interest expense
Optimal:
> 5x
|
— | — |
| Net Debt (USD) | $1.24M | — | — |
| Debt / EBITDA (x) |
-0.68x
Excellent
Excellent
Debt relative to earnings before interest, taxes, depreciation
Optimal:
< 2x
|
— | — |
Secondary lens
Benchmark Lens
Compare PASW against peers after checking the statement evidence.
Open lens
Benchmark Lens
Compare PASW against peers after checking the statement evidence.
Signals
Key bullish and bearish indicators for PASW
No bullish signals detected
Operating Margin (%) is in the bottom quartile
Profit Margin (%) is in the bottom quartile
Return on Common Equity (%) is in the bottom quartile
Percentile Rankings
How PASW compares to all companies
Peer Comparison
PASW vs similar peers
Compare PASW with peers
Stack PASW against similar companies across every metric on this page.
north_east Open comparisonbar_chart Data from SEC EDGAR XBRL filings
Synced 1 week ago 3 years · 2 quarters